Evolutionary patterns of strategic change prior to liquidation: The case of Bioglan plc

Amanda Langley, Nada K. Kakabadse, Stephen Swailes

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: This paper aims to contribute to understanding of strategy development by reporting a detailed case study of one pharmaceutical company over an 11-year period using a framework for classifying strategic actions developed from a broader study of strategic behaviour in the industry. Design-methodology-approach: The paper utilises a longitudinal text analysis using published documentary sources to explore the strategic actions and grand strategies realised by Bioglan during 1992-2002. Findings: The findings develop concepts from the economics, ecology and strategy literature in order to highlight that, rather than strategy research focusing on “with whom and how do firms compete?” the emphasis should be on “with whom and how do firms co-evolve?” Research limitations-implications: The paper only explored the realised strategies of one firm during an 11-year period using only published documentary sources. Originality-value: Previous research does not appear to have explored the evolution and co-evolution of a firm's strategic actions prior to its death, a gap that this paper aims to help to fill.

LanguageEnglish
Pages657-683
Number of pages27
JournalManagement Decision
Volume45
Issue number4
DOIs
Publication statusPublished - 8 May 2007
Externally publishedYes

Fingerprint

Liquidation
Strategic change
Evolutionary
Strategic action
Economics
Design methodology
Strategy research
Pharmaceuticals
Text analysis
Ecology
Coevolution
Strategy development
Strategic behavior
Industry

Cite this

@article{fb78c67070e142b68b642ba0bec3675c,
title = "Evolutionary patterns of strategic change prior to liquidation: The case of Bioglan plc",
abstract = "Purpose: This paper aims to contribute to understanding of strategy development by reporting a detailed case study of one pharmaceutical company over an 11-year period using a framework for classifying strategic actions developed from a broader study of strategic behaviour in the industry. Design-methodology-approach: The paper utilises a longitudinal text analysis using published documentary sources to explore the strategic actions and grand strategies realised by Bioglan during 1992-2002. Findings: The findings develop concepts from the economics, ecology and strategy literature in order to highlight that, rather than strategy research focusing on “with whom and how do firms compete?” the emphasis should be on “with whom and how do firms co-evolve?” Research limitations-implications: The paper only explored the realised strategies of one firm during an 11-year period using only published documentary sources. Originality-value: Previous research does not appear to have explored the evolution and co-evolution of a firm's strategic actions prior to its death, a gap that this paper aims to help to fill.",
keywords = "Strategic Change, Strategic choices, Pharmaceuticals industry",
author = "Amanda Langley and Kakabadse, {Nada K.} and Stephen Swailes",
year = "2007",
month = "5",
day = "8",
doi = "10.1108/00251740710745971",
language = "English",
volume = "45",
pages = "657--683",
journal = "Management Decision",
issn = "0025-1747",
publisher = "Emerald Group Publishing Ltd.",
number = "4",

}

Evolutionary patterns of strategic change prior to liquidation : The case of Bioglan plc. / Langley, Amanda; Kakabadse, Nada K.; Swailes, Stephen.

In: Management Decision, Vol. 45, No. 4, 08.05.2007, p. 657-683.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evolutionary patterns of strategic change prior to liquidation

T2 - Management Decision

AU - Langley, Amanda

AU - Kakabadse, Nada K.

AU - Swailes, Stephen

PY - 2007/5/8

Y1 - 2007/5/8

N2 - Purpose: This paper aims to contribute to understanding of strategy development by reporting a detailed case study of one pharmaceutical company over an 11-year period using a framework for classifying strategic actions developed from a broader study of strategic behaviour in the industry. Design-methodology-approach: The paper utilises a longitudinal text analysis using published documentary sources to explore the strategic actions and grand strategies realised by Bioglan during 1992-2002. Findings: The findings develop concepts from the economics, ecology and strategy literature in order to highlight that, rather than strategy research focusing on “with whom and how do firms compete?” the emphasis should be on “with whom and how do firms co-evolve?” Research limitations-implications: The paper only explored the realised strategies of one firm during an 11-year period using only published documentary sources. Originality-value: Previous research does not appear to have explored the evolution and co-evolution of a firm's strategic actions prior to its death, a gap that this paper aims to help to fill.

AB - Purpose: This paper aims to contribute to understanding of strategy development by reporting a detailed case study of one pharmaceutical company over an 11-year period using a framework for classifying strategic actions developed from a broader study of strategic behaviour in the industry. Design-methodology-approach: The paper utilises a longitudinal text analysis using published documentary sources to explore the strategic actions and grand strategies realised by Bioglan during 1992-2002. Findings: The findings develop concepts from the economics, ecology and strategy literature in order to highlight that, rather than strategy research focusing on “with whom and how do firms compete?” the emphasis should be on “with whom and how do firms co-evolve?” Research limitations-implications: The paper only explored the realised strategies of one firm during an 11-year period using only published documentary sources. Originality-value: Previous research does not appear to have explored the evolution and co-evolution of a firm's strategic actions prior to its death, a gap that this paper aims to help to fill.

KW - Strategic Change

KW - Strategic choices

KW - Pharmaceuticals industry

UR - http://www.scopus.com/inward/record.url?scp=34249701717&partnerID=8YFLogxK

U2 - 10.1108/00251740710745971

DO - 10.1108/00251740710745971

M3 - Article

VL - 45

SP - 657

EP - 683

JO - Management Decision

JF - Management Decision

SN - 0025-1747

IS - 4

ER -